Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 220

1.

Invasive Scedosporium spp. and Lomentospora prolificans Infections in Pediatric Patients: Analysis of 55 Cases from FungiScope® and the Literature.

Seidel D, Hassler A, Salmanton-García J, Koehler P, Mellinghoff SC, Carlesse F, Cheng MP, Falces-Romero I, Herbrecht R, Jover Sáenz A, Klimko N, Mareș M, Lass-Floerl C, Soler-Palacín P, Wisplinghoff H, Cornely OA, Pana Z, Lehrnbecher T.

Int J Infect Dis. 2019 Dec 18. pii: S1201-9712(19)30490-4. doi: 10.1016/j.ijid.2019.12.017. [Epub ahead of print]

2.

Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium.

Donnelly JP, Chen SC, Kauffman CA, Steinbach WJ, Baddley JW, Verweij PE, Clancy CJ, Wingard JR, Lockhart SR, Groll AH, Sorrell TC, Bassetti M, Akan H, Alexander BD, Andes D, Azoulay E, Bialek R, Bradsher RW, Bretagne S, Calandra T, Caliendo AM, Castagnola E, Cruciani M, Cuenca-Estrella M, Decker CF, Desai SR, Fisher B, Harrison T, Heussel CP, Jensen HE, Kibbler CC, Kontoyiannis DP, Kullberg BJ, Lagrou K, Lamoth F, Lehrnbecher T, Loeffler J, Lortholary O, Maertens J, Marchetti O, Marr KA, Masur H, Meis JF, Morrisey CO, Nucci M, Ostrosky-Zeichner L, Pagano L, Patterson TF, Perfect JR, Racil Z, Roilides E, Ruhnke M, Prokop CS, Shoham S, Slavin MA, Stevens DA, Thompson GR, Vazquez JA, Viscoli C, Walsh TJ, Warris A, Wheat LJ, White PL, Zaoutis TE, Pappas PG.

Clin Infect Dis. 2019 Dec 5. pii: ciz1008. doi: 10.1093/cid/ciz1008. [Epub ahead of print]

PMID:
31802125
3.

Immunosuppressive Compounds Affect the Fungal Growth and Viability of Defined Aspergillus Species.

Schmidt S, Hogardt M, Demir A, Röger F, Lehrnbecher T.

Pathogens. 2019 Nov 29;8(4). pii: E273. doi: 10.3390/pathogens8040273.

4.

Distinct Effects of Immunosuppressive Drugs on the Anti-Aspergillus Activity of Human Natural Killer Cells.

Schmidt S, Schubert R, Demir A, Lehrnbecher T.

Pathogens. 2019 Nov 19;8(4). pii: E246. doi: 10.3390/pathogens8040246.

5.

Etiology and Outcome of Candidemia in Neonates and Children in Europe: An 11-year Multinational Retrospective Study.

Warris A, Pana ZD, Oletto A, Lundin R, Castagnola E, Lehrnbecher T, Groll AH, Roilides E, Andersen CT, Arendrup MC, Arsenijevic VA, Bianchini S, von Both U, Chmelnik M, Controzzi T, Emonts M, Esposito S, Ferreras-Antolin L, Henriet S, Iosifidis E, Irwin A, Kopsidas J, Lagrou K, Lyall H, Casteleiro AM, Mesini A, Olbrich P, Paulus S, Lausch KR, Soler-Palacin P, Spyridis N, Strenger V, Theodoraki M, Wolfs T; EUROCANDY Study Group**; **EUROCANDY study group:.

Pediatr Infect Dis J. 2020 Feb;39(2):114-120. doi: 10.1097/INF.0000000000002530.

PMID:
31725552
6.

Global guideline for the diagnosis and management of mucormycosis: an initiative of the European Confederation of Medical Mycology in cooperation with the Mycoses Study Group Education and Research Consortium.

Cornely OA, Alastruey-Izquierdo A, Arenz D, Chen SCA, Dannaoui E, Hochhegger B, Hoenigl M, Jensen HE, Lagrou K, Lewis RE, Mellinghoff SC, Mer M, Pana ZD, Seidel D, Sheppard DC, Wahba R, Akova M, Alanio A, Al-Hatmi AMS, Arikan-Akdagli S, Badali H, Ben-Ami R, Bonifaz A, Bretagne S, Castagnola E, Chayakulkeeree M, Colombo AL, Corzo-León DE, Drgona L, Groll AH, Guinea J, Heussel CP, Ibrahim AS, Kanj SS, Klimko N, Lackner M, Lamoth F, Lanternier F, Lass-Floerl C, Lee DG, Lehrnbecher T, Lmimouni BE, Mares M, Maschmeyer G, Meis JF, Meletiadis J, Morrissey CO, Nucci M, Oladele R, Pagano L, Pasqualotto A, Patel A, Racil Z, Richardson M, Roilides E, Ruhnke M, Seyedmousavi S, Sidharthan N, Singh N, Sinko J, Skiada A, Slavin M, Soman R, Spellberg B, Steinbach W, Tan BH, Ullmann AJ, Vehreschild JJ, Vehreschild MJGT, Walsh TJ, White PL, Wiederhold NP, Zaoutis T, Chakrabarti A; Mucormycosis ECMM MSG Global Guideline Writing Group.

Lancet Infect Dis. 2019 Dec;19(12):e405-e421. doi: 10.1016/S1473-3099(19)30312-3. Epub 2019 Nov 5. Review.

PMID:
31699664
7.

Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation.

Lehrnbecher T, Fisher BT, Phillips B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Castagnola E, Davis BL, Dupuis LL, Egan G, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, van de Wetering M, Wolf J, Cabral S, Robinson PD, Sung L.

Clin Infect Dis. 2019 Nov 2. pii: ciz1082. doi: 10.1093/cid/ciz1082. [Epub ahead of print]

8.

Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational Study.

Donadieu J, Larabi IA, Tardieu M, Visser J, Hutter C, Sieni E, Kabbara N, Barkaoui M, Miron J, Chalard F, Milne P, Haroche J, Cohen F, Hélias-Rodzewicz Z, Simon N, Jehanne M, Kolenova A, Pagnier A, Aladjidi N, Schneider P, Plat G, Lutun A, Sonntagbauer A, Lehrnbecher T, Ferster A, Efremova V, Ahlmann M, Blanc L, Nicholson J, Lambilliote A, Boudiaf H, Lissat A, Svojgr K, Bernard F, Elitzur S, Golan M, Evseev D, Maschan M, Idbaih A, Slater O, Minkov M, Taly V, Collin M, Alvarez JC, Emile JF, Héritier S.

J Clin Oncol. 2019 Nov 1;37(31):2857-2865. doi: 10.1200/JCO.19.00456. Epub 2019 Sep 12.

PMID:
31513482
9.

Galactomannan and PCR in the Central Nervous System to Detect Invasive Mold Disease - A Retrospective Analysis in Immunocompromised Children.

Lehrnbecher T, Rath PM, Attarbaschi A, Cario G, Döring M, Moser O, Mücke U, Poyer F, Rieken S, Temme C, Voigt S, Groll AH, Lauten M.

Sci Rep. 2019 Sep 10;9(1):12950. doi: 10.1038/s41598-019-49426-0.

10.

Efficacy of antibiotic prophylaxis in patients with cancer and hematopoietic stem cell transplantation recipients: A systematic review of randomized trials.

Egan G, Robinson PD, Martinez JPD, Alexander S, Ammann RA, Dupuis LL, Fisher BT, Lehrnbecher T, Phillips B, Cabral S, Tomlinson G, Sung L.

Cancer Med. 2019 Aug;8(10):4536-4546. doi: 10.1002/cam4.2395. Epub 2019 Jul 5. Review.

11.

Pre-emptive versus empirical antifungal therapy in immunocompromised children.

Lehrnbecher T, Groll AH.

Lancet Child Adolesc Health. 2019 Aug;3(8):518-520. doi: 10.1016/S2352-4642(19)30191-9. Epub 2019 Jun 13. No abstract available.

PMID:
31204310
12.

ESCMID-ECMM guideline: diagnosis and management of invasive aspergillosis in neonates and children.

Warris A, Lehrnbecher T, Roilides E, Castagnola E, Brüggemann RJM, Groll AH.

Clin Microbiol Infect. 2019 Sep;25(9):1096-1113. doi: 10.1016/j.cmi.2019.05.019. Epub 2019 May 31.

PMID:
31158517
13.

The clinical management of invasive mold infection in children with cancer or undergoing hematopoietic stem cell transplantation.

Lehrnbecher T.

Expert Rev Anti Infect Ther. 2019 Jul;17(7):489-499. doi: 10.1080/14787210.2019.1626718. Epub 2019 Jun 8.

PMID:
31149864
14.

Allogeneic hematopoietic stem cell transplantation from unrelated donors is associated with higher infection rates in children with acute lymphoblastic leukemia-A prospective international multicenter trial on behalf of the BFM-SG and the EBMT-PDWP.

Pichler H, Lawitschka A, Glogova E, Willasch AM, von Luettichau I, Lehrnbecher T, Matthes-Martin S, Lang P, Bader P, Sykora KW, Schrum J, Kremens B, Ehlert K, Albert MH, Kuhlen M, Meisel R, Guengoer T, Strahm B, Gruhn B, Schulz A, Woessmann W, Poetschger U, Peters C.

Am J Hematol. 2019 Aug;94(8):880-890. doi: 10.1002/ajh.25511. Epub 2019 May 29.

15.

Extended Dosing Regimens for Fungal Prophylaxis.

Lehrnbecher T, Bochennek K, Klingebiel T, Gastine S, Hempel G, Groll AH.

Clin Microbiol Rev. 2019 May 15;32(3). pii: e00010-19. doi: 10.1128/CMR.00010-19. Print 2019 Jun 19. Review.

PMID:
31092507
16.

Invasive mold disease of the central nervous system in children and adolescents with cancer or undergoing hematopoietic stem cell transplantation: Analysis of 29 contemporary patients.

Lauten M, Attarbaschi A, Cario G, Döring M, Moser O, Mücke U, Poyer F, Rieken S, Temme C, Voigt S, Lehrnbecher T, Groll AH.

Pediatr Blood Cancer. 2019 Aug;66(8):e27806. doi: 10.1002/pbc.27806. Epub 2019 May 7.

PMID:
31066209
17.

Incidence and Outcome of Invasive Fungal Diseases in Children With Hematological Malignancies and/or Allogeneic Hematopoietic Stem Cell Transplantation: Results of a Prospective Multicenter Study.

Lehrnbecher T, Schöning S, Poyer F, Georg J, Becker A, Gordon K, Attarbaschi A, Groll AH.

Front Microbiol. 2019 Apr 16;10:681. doi: 10.3389/fmicb.2019.00681. eCollection 2019.

18.

A non-randomized trial to assess the safety, tolerability, and pharmacokinetics of posaconazole oral suspension in immunocompromised children with neutropenia.

Arrieta AC, Sung L, Bradley JS, Zwaan CM, Gates D, Waskin H, Carmelitano P, Groll AH, Lehrnbecher T, Mangin E, Joshi A, Kartsonis NA, Walsh TJ, Paschke A.

PLoS One. 2019 Mar 26;14(3):e0212837. doi: 10.1371/journal.pone.0212837. eCollection 2019.

19.

Why are natural killer cells important for defense against Aspergillus?

Lehrnbecher T, Schmidt S.

Med Mycol. 2019 Apr 1;57(Supplement_2):S206-S210. doi: 10.1093/mmy/myy034. Review.

PMID:
30816962
20.

Pontine tumor in a neonate: case report and analysis of the current literature.

Buus-Gehrig C, Lehrnbecher T, Porto L, Becker M, Freiman T, Mittelbronn M, Bochennek K.

J Neurosurg Pediatr. 2019 Feb 15:1-7. doi: 10.3171/2018.10.PEDS18215. [Epub ahead of print]

PMID:
30771760
21.

Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Mikulska M, Cesaro S, de Lavallade H, Di Blasi R, Einarsdottir S, Gallo G, Rieger C, Engelhard D, Lehrnbecher T, Ljungman P, Cordonnier C; European Conference on Infections in Leukaemia group.

Lancet Infect Dis. 2019 Jun;19(6):e188-e199. doi: 10.1016/S1473-3099(18)30601-7. Epub 2019 Feb 8. Review. Erratum in: Lancet Infect Dis. 2019 Apr;19(4):e109.

PMID:
30744964
22.

Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7).

Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, Ljungman P; European Conference on Infections in Leukaemia group.

Lancet Infect Dis. 2019 Jun;19(6):e200-e212. doi: 10.1016/S1473-3099(18)30600-5. Epub 2019 Feb 8. Review.

PMID:
30744963
23.

Revaccination in Children Undergoing Autologous Hematopoietic Stem Cell Transplantation: Results of a Survey in Germany, Austria and Switzerland.

Laws HJ, Simon A, Lehrnbecher T.

Klin Padiatr. 2019 May;231(3):136-141. doi: 10.1055/a-0796-6719. Epub 2019 Jan 2.

PMID:
30602176
24.

Longitudinal assessment of peripheral blood BRAFV600E levels in patients with Langerhans cell histiocytosis.

Schwentner R, Kolenová A, Jug G, Schnöller T, Ahlmann M, Meister B, Lehrnbecher T, Minkov M, Hutter C.

Pediatr Res. 2019 May;85(6):856-864. doi: 10.1038/s41390-018-0238-y. Epub 2018 Nov 24.

PMID:
30474648
25.

Treatment of fever in neutropenia in pediatric oncology patients.

Lehrnbecher T.

Curr Opin Pediatr. 2019 Feb;31(1):35-40. doi: 10.1097/MOP.0000000000000708.

PMID:
30461508
26.

Impact of Antifungal Compounds on Viability and Anti-Aspergillus Activity of Human Natural Killer Cells.

Schmidt S, Schubert R, Tramsen L, Lehrnbecher T.

Antimicrob Agents Chemother. 2019 Jan 29;63(2). pii: e01993-18. doi: 10.1128/AAC.01993-18. Print 2019 Feb.

27.

Guideline for the Management of Clostridium Difficile Infection in Children and Adolescents With Cancer and Pediatric Hematopoietic Stem-Cell Transplantation Recipients.

Diorio C, Robinson PD, Ammann RA, Castagnola E, Erickson K, Esbenshade A, Fisher BT, Haeusler GM, Kuczynski S, Lehrnbecher T, Phillips R, Cabral S, Dupuis LL, Sung L.

J Clin Oncol. 2018 Sep 14:JCO1800407. doi: 10.1200/JCO.18.00407. [Epub ahead of print]

28.

Vemurafenib in Langerhans cell histiocytosis: report of a pediatric patient and review of the literature.

Heisig A, Sörensen J, Zimmermann SY, Schöning S, Schwabe D, Kvasnicka HM, Schwentner R, Hutter C, Lehrnbecher T.

Oncotarget. 2018 Apr 24;9(31):22236-22240. doi: 10.18632/oncotarget.25277. eCollection 2018 Apr 24.

29.

Natural killer cells as a therapeutic tool for infectious diseases - current status and future perspectives.

Schmidt S, Tramsen L, Rais B, Ullrich E, Lehrnbecher T.

Oncotarget. 2018 Apr 17;9(29):20891-20907. doi: 10.18632/oncotarget.25058. eCollection 2018 Apr 17. Review.

30.

Diagnostic Approaches for Invasive Aspergillosis-Specific Considerations in the Pediatric Population.

Lehrnbecher T, Hassler A, Groll AH, Bochennek K.

Front Microbiol. 2018 Mar 26;9:518. doi: 10.3389/fmicb.2018.00518. eCollection 2018. Review.

31.

[Recommendations for Diagnostics and Therapy of Children with Cancer Presenting with Fever and Neutropenia - Comparison of Two Current Guidelines].

Lehrnbecher T, Groll A, Agyeman P, Ammann RA, Attarbaschi A, Behrends U, Berger C, Hamprecht A, Hufnagel M, Laws HJ, Scheler M, Temme C, Vieth S, Simon A.

Klin Padiatr. 2018 Apr;230(3):115-121. doi: 10.1055/s-0044-101953. Epub 2018 Mar 27. Review. German.

PMID:
29589346
32.

Successes and challenges in the treatment of pediatric acute myeloid leukemia: a retrospective analysis of the AML-BFM trials from 1987 to 2012.

Rasche M, Zimmermann M, Borschel L, Bourquin JP, Dworzak M, Klingebiel T, Lehrnbecher T, Creutzig U, Klusmann JH, Reinhardt D.

Leukemia. 2018 Oct;32(10):2167-2177. doi: 10.1038/s41375-018-0071-7. Epub 2018 Feb 22.

33.

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline.

Ullmann AJ, Aguado JM, Arikan-Akdagli S, Denning DW, Groll AH, Lagrou K, Lass-Flörl C, Lewis RE, Munoz P, Verweij PE, Warris A, Ader F, Akova M, Arendrup MC, Barnes RA, Beigelman-Aubry C, Blot S, Bouza E, Brüggemann RJM, Buchheidt D, Cadranel J, Castagnola E, Chakrabarti A, Cuenca-Estrella M, Dimopoulos G, Fortun J, Gangneux JP, Garbino J, Heinz WJ, Herbrecht R, Heussel CP, Kibbler CC, Klimko N, Kullberg BJ, Lange C, Lehrnbecher T, Löffler J, Lortholary O, Maertens J, Marchetti O, Meis JF, Pagano L, Ribaud P, Richardson M, Roilides E, Ruhnke M, Sanguinetti M, Sheppard DC, Sinkó J, Skiada A, Vehreschild MJGT, Viscoli C, Cornely OA.

Clin Microbiol Infect. 2018 May;24 Suppl 1:e1-e38. doi: 10.1016/j.cmi.2018.01.002. Epub 2018 Mar 12.

34.

NK Cells and Their Role in Invasive Mold Infection.

Schmidt S, Condorelli A, Koltze A, Lehrnbecher T.

J Fungi (Basel). 2017 May 19;3(2). pii: E25. doi: 10.3390/jof3020025. Review.

35.

Crizotinib in ALK+ inflammatory myofibroblastic tumors-Current experience and future perspectives.

Theilen TM, Soerensen J, Bochennek K, Becker M, Schwabe D, Rolle U, Klingebiel T, Lehrnbecher T.

Pediatr Blood Cancer. 2018 Apr;65(4). doi: 10.1002/pbc.26920. Epub 2017 Dec 29. Review.

PMID:
29286567
36.

Impact of human mesenchymal stromal cells on antifungal host response against Aspergillus fumigatus.

Schmidt S, Tramsen L, Schneider A, Schubert R, Balan A, Degistirici Ö, Meisel R, Lehrnbecher T.

Oncotarget. 2017 Sep 8;8(56):95495-95503. doi: 10.18632/oncotarget.20753. eCollection 2017 Nov 10.

37.

Natural Killer Cells in Antifungal Immunity.

Schmidt S, Tramsen L, Lehrnbecher T.

Front Immunol. 2017 Nov 22;8:1623. doi: 10.3389/fimmu.2017.01623. eCollection 2017. Review.

38.

Pharmacokinetic Modeling of Voriconazole To Develop an Alternative Dosing Regimen in Children.

Gastine S, Lehrnbecher T, Müller C, Farowski F, Bader P, Ullmann-Moskovits J, Cornely OA, Groll AH, Hempel G.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e01194-17. doi: 10.1128/AAC.01194-17. Print 2018 Jan.

39.

Role of Molecular Biomarkers in the Diagnosis of Invasive Fungal Diseases in Children.

Huppler AR, Fisher BT, Lehrnbecher T, Walsh TJ, Steinbach WJ.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S32-S44. doi: 10.1093/jpids/pix054. Review.

40.

Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.

King J, Pana ZD, Lehrnbecher T, Steinbach WJ, Warris A.

J Pediatric Infect Dis Soc. 2017 Sep 1;6(suppl_1):S12-S21. doi: 10.1093/jpids/pix053. Review.

41.

Progress in the Diagnosis of Invasive Fungal Disease in Children.

Warris A, Lehrnbecher T.

Curr Fungal Infect Rep. 2017;11(2):35-44. doi: 10.1007/s12281-017-0274-9. Epub 2017 May 2. Review.

42.

Risk Factors for Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review.

Fisher BT, Robinson PD, Lehrnbecher T, Steinbach WJ, Zaoutis TE, Phillips B, Sung L.

J Pediatric Infect Dis Soc. 2018 Aug 17;7(3):191-198. doi: 10.1093/jpids/pix030. Review.

43.

Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update.

Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, Carlesse F, Groll AH, Haeusler GM, Santolaya M, Steinbach WJ, Castagnola E, Davis BL, Dupuis LL, Gaur AH, Tissing WJE, Zaoutis T, Phillips R, Sung L.

J Clin Oncol. 2017 Jun 20;35(18):2082-2094. doi: 10.1200/JCO.2016.71.7017. Epub 2017 May 1. Review.

PMID:
28459614
44.

Genotype-outcome correlations in pediatric AML: the impact of a monosomal karyotype in trial AML-BFM 2004.

Rasche M, von Neuhoff C, Dworzak M, Bourquin JP, Bradtke J, Göhring G, Escherich G, Fleischhack G, Graf N, Gruhn B, Haas OA, Klingebiel T, Kremens B, Lehrnbecher T, von Stackelberg A, Tchinda J, Zemanova Z, Thiede C, von Neuhoff N, Zimmermann M, Creutzig U, Reinhardt D.

Leukemia. 2017 Dec;31(12):2807-2814. doi: 10.1038/leu.2017.121. Epub 2017 Apr 25.

45.

The Non-Langerhans Cell Histiocytoses (Rare Histiocytoses) - Clinical Aspects and Therapeutic Approaches.

Classen CF, Minkov M, Lehrnbecher T.

Klin Padiatr. 2016 Nov;228(6-07):294-306. Epub 2016 Nov 15. Review.

PMID:
27846659
46.

Disseminated Fusariosis in Immunocompromised Children-Analysis of Recent Cases Identified in the Global Fungiscope Registry.

Hassler A, Lieb A, Seidel D, Cesaro S, Greil J, Klimko N, Khostelidi S, Solopova G, Ogunc D, Durán Graeff L, Cornely OA, Vehreschild MJ, Lehrnbecher T.

Pediatr Infect Dis J. 2017 Feb;36(2):230-231. doi: 10.1097/INF.0000000000001396.

PMID:
27846057
47.

Current Algorithms in Fungal Diagnosis in the Immunocompromised Host.

Lehrnbecher T, Becker K, Groll AH.

Methods Mol Biol. 2017;1508:67-84.

PMID:
27837498
48.

Role of natural killer cells in antibacterial immunity.

Schmidt S, Ullrich E, Bochennek K, Zimmermann SY, Lehrnbecher T.

Expert Rev Hematol. 2016 Dec;9(12):1119-1127. Epub 2016 Nov 11. Review.

PMID:
27791439
49.

Galactomannan, β-D-Glucan, and Polymerase Chain Reaction-Based Assays for the Diagnosis of Invasive Fungal Disease in Pediatric Cancer and Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-Analysis.

Lehrnbecher T, Robinson PD, Fisher BT, Castagnola E, Groll AH, Steinbach WJ, Zaoutis TE, Negeri ZF, Beyene J, Phillips B, Sung L.

Clin Infect Dis. 2016 Nov 15;63(10):1340-1348. Epub 2016 Aug 27. Review.

50.

Aspergillus fumigatus responds to natural killer (NK) cells with upregulation of stress related genes and inhibits the immunoregulatory function of NK cells.

Schneider A, Blatzer M, Posch W, Schubert R, Lass-Flörl C, Schmidt S, Lehrnbecher T.

Oncotarget. 2016 Nov 1;7(44):71062-71071. doi: 10.18632/oncotarget.12616.

Supplemental Content

Loading ...
Support Center